SCHEMBL2721771

SCHEMBL2721771

NC(n1nnc2ccccc21)n1nnc2ccccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
CYP1A2 P05177 2/20 0.55
MAPT P10636 2/20 0.55
CYP3A4 P08684 1/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
THPO P40225 1/20 0.55
CYP4Z1 Q86W10 1/20 0.55
SLC9A1 P19634 8/20 0.50
POLB P06746 1/20 0.50
MAPK1 P28482 1/20 0.50
ATM Q13315 1/20 0.50
KEAP1 Q14145 1/20 0.50
DGAT1 O75907 1/20 0.46
GRM2 Q14416 1/20 0.43
RAB9A P51151 2/20 0.42
KCNMA1 Q12791 1/20 0.42
MGAM O43451 1/20 0.41
F2 P00734 1/20 0.41
AMY1A P0DUB6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20294466 0.88 ALDH1A1 (0.55) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6
SCHEMBL13275470 0.87 ALDH1A1 (0.47) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6
SCHEMBL8060038 0.84 ALDH1A1 (0.52) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6
SCHEMBL26427177 0.84 SLC9A1 (0.52) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6
SCHEMBL29479858 0.83 SLC9A1 (0.54) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6
SCHEMBL6794284 0.83 SLC9A1 (0.54) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6
SCHEMBL8601954 0.81 MAPT (0.48) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6
SCHEMBL7526304 0.80 ALDH1A1 (0.47) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6
SCHEMBL5200373 0.80 ALDH1A1 (0.47) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6
SCHEMBL1083846 0.79 ALDH1A1 (0.58) ALDH1A1CYP1A2MAPTCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130225583-A1 SUBSTITUTED AMINO-TRIAZOLYL PDE10 INHIBITORS MERCK SHARP & DOHME CORP. 2013-08-29 US disclosed
EP-2629616-A2 SUBSTITUTED AMINO-TRIAZOLYL PDE10 INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-08-28 EP disclosed
WO-2012054366-A2 SUBSTITUTED AMINO-TRIAZOLYL PDE10 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225583-A1 SUBSTITUTED AMINO-TRIAZOLYL PDE10 INHIBITORS PDE10A, PDE12, PDE4A ALDH1A1 1409/4885CYP1A2 1938/4885MAPT 1309/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.